PillRx only · Injection, Solution · Intravenous
Insulin Aspart-Szjj
Brands: Merilog · Insulin Aspart
1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US2 NDCs
1 active makers
1 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$7.767
Latest avg · Jul 22, 2026
-11%
Since Apr 22, 2026
1
Active US suppliers
100%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Only one quarter on record so far — the trend line fills in as more quarters load.
556
Rx · 2026 Q1
12K
Units dispensed
1
Quarters · since 2026 Q1
Who makes it1 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | unknown | 2 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.